Popular Posts Today

Diberdayakan oleh Blogger.

Mechanism that leads to diabetes, blindness, identified

Written By Unknown on Senin, 17 September 2012 | 12.36

ScienceDaily (Sep. 16, 2012) — The rare disorder Wolfram syndrome is caused by mutations in a single gene, but its effects on the body are far reaching. The disease leads to diabetes, hearing and vision loss, nerve cell damage that causes motor difficulties, and early death.

Now, researchers at Washington University School of Medicine in St. Louis, the Joslin Diabetes Center in Boston and the Novartis Institutes for BioMedical Research report that they have identified a mechanism related to mutations in the WFS1 gene that affects insulin-secreting beta cells. The finding will aid in the understanding of Wolfram syndrome and also may be important in the treatment of milder forms of diabetes and other disorders.

The study is published online in the journal Nature Cell Biology.

Insulin-secreting beta cells in the pancreas (above) cannot make enough cyclic AMP in patients with Wolfram syndrome. As a result, the pancreas produces and secretes less insulin, and the cells eventually die.

"We found something we didn't expect," says researcher Fumihiko Urano, MD, PhD, associate professor of medicine in Washington University's Division of Endocrinology, Metabolism and Lipid Research. "The study showed that the WFS1 gene is crucial to producing a key molecule involved in controlling the metabolic activities of individual cells." That molecule is called cyclic AMP (cyclic adenosine monophosphate).

In insulin-secreting beta cells in the pancreas, for example, cyclic AMP rises in response to high blood sugar, causing those cells to produce and secrete insulin.

"I would compare cyclic AMP to money," Urano says. "You can't just take something you make to the store and use it to buy food. First, you have to convert it into money. Then, you use the money to buy food. In the body, external signals stimulate a cell to make cyclic AMP, and then the cyclic AMP, like money, can 'buy' insulin or whatever else may be needed."

The reason patients with Wolfram syndrome experience so many problems, he says, is because mutations in the WFS1 gene interfere with cyclic AMP production in beta cells in the pancreas.

"In patients with Wolfram syndrome, there is no available WFS1 protein, and that protein is key in cyclic AMP production," he explains. "Then, because levels of cyclic AMP are low in insulin-secreting beta cells, those cells produce and secrete less insulin. And in nerve cells, less cyclic AMP can lead to nerve cell dysfunction and death."

By finding that cyclic AMP production is affected by mutations in the WFS1 gene, researchers now have a potential target for understanding and treating Wolfram syndrome.

"I don't know whether we can find a way to control cyclic AMP production in specific tissues," he says. "But if that's possible, it could help a great deal."

Meanwhile, although Wolfram syndrome is rare, affecting about 1 in 500,000 people, Urano says the findings also may be important to more common disorders.

"It's likely this mechanism is related to diseases such as type 2 diabetes," he says. "If a complete absence of the WFS1 protein causes Wolfram syndrome, perhaps a partial impairment leads to something milder, like diabetes."

Funding for this research comes from the JDRF, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Center for Research Resources of the National Institutes of Health (NIH). NIH grant numbers DK067493, DK016746, P60 DK020579, RR024992, and UL1 TR000448.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Washington University School of Medicine. The original article was written by Jim Dryden.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Sonya G. Fonseca, Fumihiko Urano, Gordon C. Weir, Jesper Gromada, Mark Burcin. Wolfram syndrome 1 and adenylyl cyclase 8 interact at the plasma membrane to regulate insulin production and secretion. Nature Cell Biology, 2012; DOI: 10.1038/ncb2578

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

18 Sep, 2012


-
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/k2rMYPgU7U4/120917123847.htm
--
Manage subscription | Powered by rssforward.com
12.36 | 0 komentar | Read More

Toxic protein build-up in blood shines light on fatal brain disease

ScienceDaily (Sep. 17, 2012) — A new light-based technique for measuring levels of the toxic protein that causes Huntington's disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells. Published September 17 in the Journal of Clinical Investigation, the findings shed light on how the protein causes damage in the brain, and could be useful for monitoring the progression of HD, or testing new drugs aimed at suppressing production of the harmful protein.

HD is a fatal, incurable, genetic neurological disease that usually develops in adulthood and causes abnormal involuntary movements, psychiatric symptoms and dementia. It is caused by a genetic mutation that results in the production of a harmful protein, called mutant huntingtin.

The research team, led by Professor Sarah Tabrizi of the UCL Institute of Neurology, was made up of scientists from UCL, the Novartis Institutes for Biomedical Research and King's College London. They used a new, ultra-sensitive test to measure how much of the harmful protein and its normal counterpart are found in blood cells from HD patients at different stages of the disease. The test, called TR-FRET, uses pairs of antibodies that stick to huntingtin molecules to absorb and emit light of different colours. This enables very tiny amounts of huntingtin to be detected with great accuracy.

The researchers found that levels of the harmful mutant huntingtin protein built up gradually over the course of the disease, from before the patients show any symptoms onwards. HD causes the brain to shrink more rapidly than normal, as measured using MRI scans. Surprisingly, the amount of mutant protein in white blood cells corresponded to the rate of brain shrinkage. This is the first time a blood test has been able to predict brain shrinkage in a neurodegenerative disease. Levels of the normal huntingtin protein, on the other hand, stayed constant throughout the disease.

The team went on to demonstrate that small fragments of the most toxic part of the protein were slowly building-up in the white blood cells -- the first time this has been demonstrated in cells from human HD patients. If a similar process occurs in brain cells such as neurons, this finding may help explain how the damage gradually accumulates, eventually causing symptoms of HD.

This build-up of the mutant protein in the white blood cells of the immune system may also explain previous findings by Professor Tabrizi's team which showed that the immune system is hyperactive in HD.

"Measuring levels of the mutant protein using TR-FRET is a useful new tool in the fight against HD," said Professor Tabrizi. "We can now accurately study the most toxic form of the huntingtin protein in easily obtained blood samples from real patients. The fact that mutant huntingtin levels correlate with brain atrophy tells us we're dealing with something that's relevant to the process of brain degeneration in HD."

The new technique could also be an asset for forthcoming clinical trials of 'gene silencing' drugs that aim to suppress production of the toxic protein in the brain.

"Gene silencing drugs are very promising, but have significant potential for causing side effects, so we really need to know they're doing their job of lowering huntingtin levels," continued Professor Tabrizi. "This TR-FRET technique offers a way of showing that in real human samples, and we hope that it will help speed up the process of developing drugs that work to slow down this terrible disease."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by University College London, via EurekAlert!, a service of AAAS.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Andreas Weiss, Ulrike Träger, Edward J. Wild, Stephan Grueninger, Ruth Farmer, Christian Landles, Rachael I. Scahill, Nayana Lahiri, Salman Haider, Douglas Macdonald, Chris Frost, Gillian P. Bates, Graeme Bilbe, Rainer Kuhn, Ralph Andre and Sarah J. Tabrizi. Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression. Journal of Clinical Investigation, 2012 DOI: 10.1172/JCI64565

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

18 Sep, 2012


-
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/YiOblUStlYs/120917123933.htm
--
Manage subscription | Powered by rssforward.com
12.36 | 0 komentar | Read More

Eating well during pregnancy reduces baby's obesity risk regardless of mom's size

ScienceDaily (Sep. 17, 2012) — If you are overweight and pregnant, your baby isn't destined to a life of obesity after all, according to a new research report published online in The FASEB Journal. In the report, a team of U.S. scientists show that modifying fat intake during pregnancy to a moderate level is enough to benefit the child regardless of the mother's size. Specifically, they found that a protein called "SIRT1" rewrites a developing fetus' histone code, which affects his or her "epigenetic likelihood" of being overweight or obese throughout his or her lifetime.

"We are finding that the cycle of obesity likely begins in the womb, however, we are also finding that obesity does not necessarily beget obesity," said Kjersti M. Aagaard, M.D., Ph.D., study author from the Division of Maternal-Fetal Medicine and the Department of Obstetrics and Gynecology at Baylor College of Medicine in Houston, Texas. "A diet laden with fat changes the molecular machinery which chemically modifies the structure of the developing infant's genetic material. These commonly called 'histone code' changes are rewritten-at least in part-by SIRT1, which in turn, alters key regulators of fat and glucose metabolism in the infant. It is our hope that these early steps will in turn break the cycle of obesity in the generations to come."

To make this discovery, Aagaard and colleagues used three groups of pregnant primates. The first group ate a healthy pregnancy diet (13 percent fat), while the second group ate a high fat diet (35 percent fat) and became obese. The third group was kept on a high fat diet for several years, became obese, and then was put on a healthy diet. Researchers were able to tease apart the effects on the infant of being exposed during pregnancy to a healthy diet versus an unhealthy high fat diet. The sirtuins and the proteins, and the genes regulating glucose and fat metabolism were analyzed. Results suggest that the livers of infants exposed to the high fat diet, showed less SIRT1 and less sirtuin activity than in the control group. However, infants exposed to a healthy pregnancy diet in both lean and obese groups had restored sirtuin. To prove that SIRT1 was specifically chemically modifying the histone code, scientists created a dead enzyme version. Using high level mass spectrometry, it was discovered that while the live enzyme version of SIRT1 was very good at chemically modifying histone proteins (specifically "deacetylating" histone protein H3) the dead version was not.

"What this study shows once again is that eating a healthy diet while pregnant holds true, regardless of your size or shape," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "Even if a woman isn't eating well before pregnancy, adopting good eating habits during pregnancy is still very good for the child and for her. This new report shows how diet affects offspring at the molecular level and points to new treatments for overweight people who were not fortunate enough to have mothers who ate well during pregnancy."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Federation of American Societies for Experimental Biology, via EurekAlert!, a service of AAAS.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. M. A. Suter, A. Chen, M. S. Burdine, M. Choudhury, R. A. Harris, R. H. Lane, J. E. Friedman, K. L. Grove, A. J. Tackett, K. M. Aagaard. A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates. The FASEB Journal, 2012; DOI: 10.1096/fj.12-212878

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

18 Sep, 2012


-
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/SaKXO5DttOg/120917123841.htm
--
Manage subscription | Powered by rssforward.com
12.03 | 0 komentar | Read More

About half of adults say schools should take action when kids bully with social isolation

ScienceDaily (Sep. 17, 2012) — U.S. adults repeatedly rate bullying as a major health problem for U.S. children. But a new poll from the University of Michigan shows adults have different views about what bullying behaviors should prompt schools to take action.

The University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health recently asked a nationwide sample of adults what behaviors should be considered bullying and what behaviors should spur school officials to intervene.

The vast majority of adults (95 percent) say schools should take action if a student makes another student afraid for his/her physical safety. Eighty-one percent said schools should intervene when someone humiliates or embarrasses another student and 76 percent call for intervention when someone spreads rumors.

But only 56 percent said isolating a student socially should prompt school intervention.

"The key finding from this poll is that adults don't see behaviors across the bullying spectrum as equivalent," says Matthew M. Davis M.D., M.A.P.P., director of the C.S. Mott Children's Hospital National Poll on Children's Health.

"This is concerning because isolating a student socially is considered to be a form of bullying, and a dangerous one," says Davis, associate professor of pediatrics and internal medicine at the U-M Medical School and associate professor of public policy at the Gerald R. Ford School of Public Policy.

"Isolating a student socially may be linked to episodes of school violence and also teen suicide."

Since year 2000, 46 states have passed laws related to bullying and 45 of them require schools to have bullying policies. But not all states have the same definition of what constitutes bullying, and the poll indicates that adults don't agree on this either.

In the poll, nearly all adults (90 percent) say threatening another student's physical safety is bullying and 62 percent also say embarrassing or humiliating a student is definitely bullying.

But just 59 percent say spreading rumors about a student is bullying and only 48 percent say isolating a student socially should be considered bullying.

Since the shooting at Columbine High School in 1999, and with subsequent school shootings and teen suicides linked to bullying, public concern about bullying has grown considerably in the U.S. In the last several years of the Poll's 'Top 10' list of greatest child health concerns, bullying has been rated by the public as a major problem for kids. The latest national data from the Youth Risk Behavior Survey in 2011, reported by the national Centers for Disease Control and Prevention, indicate that 20% of high school students report that they have been the victims of bullying.

"As school starts, this is the perfect time of year to have conversations about how each school can find solutions to the problems of bullying and address this important childhood health problem," says Davis.

Full report: http://mottnpch.org/reports-surveys/bullying-when-should-schools-take-action

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by University of Michigan Health System.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

18 Sep, 2012


-
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/L3u4mFa1aRc/120917132343.htm
--
Manage subscription | Powered by rssforward.com
11.34 | 0 komentar | Read More

Adequate sleep helps weight loss

ScienceDaily (Sep. 17, 2012) — Adequate sleep is an important part of a weight loss plan and should be added to the recommended mix of diet and exercise, states a commentary in CMAJ (Canadian Medical Association Journal).

Although calorie restriction and increased physical activity are recommended for weight loss, there is significant evidence that inadequate sleep is contributing to obesity. Lack of sleep increases the stimulus to consume more food and increases appetite-regulating hormones.

"The solution [to weight loss] is not as simple as 'eat less, move more, sleep more,'" write Drs. Jean-Phillippe Chaput, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario and Angelo Tremblay, Laval University, Québec, Quebec. "However, an accumulating body of evidence suggests that sleeping habits should not be overlooked when prescribing a weight-reduction program to a patient with obesity. Sleep should be included as part of the lifestyle package that traditionally has focused on diet and physical activity."

The authors' recently published research found that total sleep time and quality of sleep predicted the loss of fat in people enrolled in a weight loss program.

The Canadian Obesity Network has included adequate sleep in its new set of obesity management tools for physicians.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Canadian Medical Association Journal, via EurekAlert!, a service of AAAS.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Jean-Philippe Chaput and Angelo Tremblay. Adequate sleep to improve the treatment of obesity. CMAJ, September 17, 2012 DOI: 10.1503/cmaj.120876

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

18 Sep, 2012


-
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/DBRhQZHqah8/120917123926.htm
--
Manage subscription | Powered by rssforward.com
11.34 | 0 komentar | Read More

Prenatal damage from dioxin shown to involve microRNAs

ScienceDaily (Sep. 17, 2012) — Research carried out at the University of South Carolina has identified novel mechanisms through which dioxin, a well-known environmental contaminant, can alter physiological functions, according to a study published online in the journal PLOS ONE.

The research team, which included Narendra Singh, Mitzi Nagarkatti and Prakash Nagarkatti of the USC School of Medicine, demonstrated that exposure to dioxin (TCDD) during pregnancy in an experimental mouse model can cause significant toxicity to the fetus, and specifically to the organs that produce the immune cells that fight infections. They found that dioxin alters small molecules called microRNAs, which can affect the expression of a large number of genes.

The study examined over 608 microRNAs, and 78 of these were significantly altered following exposure to dioxin. On the basis of the pattern of changes in these molecules, the team was also able to predict that dioxin can alter several genes that regulate cancer. Many other physiological systems were also affected, including those involved in reproductive, gastrointestinal, hematological, inflammation, renal and urological diseases as well as genetic, endocrine and developmental disorders.

Dioxin is a highly toxic chemical produced as a byproduct of industrial processes, such as the manufacture of herbicides or pesticides or the bleaching of paper. Because it degrades slowly in the environment and is soluble in fats, dioxin can bio-accumulate in the food chain and is often found in high concentrations in the milk and fat of animals in contaminated regions.

"Our results lend more credence to the hypothesis that fetal exposure to environmental contaminants can have life-long effects," said Mitzi Nagarkatti. "Prenatal damage to the expression of microRNAs in the immune system could well impact the adult immune response."

The research was supported in part by the National Institutes of Health (R01ES09098, P01AT003961, R01AT006888, R01ES019313, R01MH094755) and the Veterans Administration (VA Merit Award 1I01BX001357).

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by University of South Carolina.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Narendra P. Singh, Udai P. Singh, Hongbing Guan, Prakash Nagarkatti, Mitzi Nagarkatti. Prenatal Exposure to TCDD Triggers Significant Modulation of microRNA Expression Profile in the Thymus That Affects Consequent Gene Expression. PLoS ONE, 2012; 7 (9): e45054 DOI: 10.1371/journal.pone.0045054

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

18 Sep, 2012


-
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/orMZjD80psY/120917124345.htm
--
Manage subscription | Powered by rssforward.com
11.34 | 0 komentar | Read More

Improving memory for specific events can alleviate symptoms of depression

ScienceDaily (Sep. 17, 2012) — Hear the word "party" and memories of your 8th birthday sleepover or the big bash you attended last New Year's may come rushing to mind. But it's exactly these kinds of memories, embedded in a specific place and time, that people with depression have difficulty recalling.

Research has shown that people who suffer from, or are at risk of, depression have difficulty tapping into specific memories from their own past, an impairment that affects their ability to solve problems and leads them to focus on feelings of distress.

In a study forthcoming in Clinical Psychological Science, a new journal of the Association for Psychological Science, psychological scientists Hamid Neshat-Doost of the University of Isfahan, Iran, Laura Jobson of the University of East Anglia, Tim Dalgleish of the Cognition and Brain Sciences Unit, Medical Research Council, Cambridge and colleagues investigated whether a particular training program, Memory Specificity Training, might improve people's memory for past events and ameliorate their symptoms of depression.

In Iran, the researchers recruited 23 adolescent Afghani refugees who had lost their fathers in the war in Afghanistan and who showed symptoms of depression. Twelve of the adolescents were randomly assigned to participate in the memory training program and 11 were randomly assigned to a control group that received no training.

All of the adolescents completed a memory test in which they saw 18 positive, neutral, and negative words in Persian and were asked to recall a specific memory related to each word. Their responses were categorized as either a specific or a non-specific type of memory. They also completed questionnaires design to measure symptoms of depression and anxiety symptoms.

For five weeks, the adolescents assigned to the training attended a weekly 80-minute group session, in which they learned about different types of memory and memory recall, and practiced recalling specific memories after being given positive, neutral, and negative keywords.

At the end of the five weeks, both the training group and the control group were given the same memory test that they were given at the beginning of the study. And they took the memory test again as part of a follow-up visit two months later.

The adolescents who participated in the training were able to provide more specific memories after the training than those who did not receive intervention. They also showed fewer symptoms of depression than the control group at the two month follow-up. The researchers found that the relationship between participant group (training or control) and their symptoms of depression at follow-up could be accounted for by changes in specific memory recall over time.

These findings are promising because they suggest that a standalone training program that focuses on specific memory recall can actually improve depression symptoms.

Based on the results of this study, Jobson, Dalgleish, and colleagues conclude that, for individuals suffering from depression, "including a brief training component that targets memory recall as an adjunct to cognitive behavioral therapy or prior therapy may have beneficial effects on memory recall and mood."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Association for Psychological Science.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

18 Sep, 2012


-
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/PUll8wC6SgU/120917132341.htm
--
Manage subscription | Powered by rssforward.com
11.04 | 0 komentar | Read More

Sex matters: Men recognize cars and women recognize living things best, psychological analysis finds

ScienceDaily (Sep. 17, 2012) — Women are better than men at recognizing living things and men are better than women at recognizing vehicles.

That is the unanticipated result of an analysis Vanderbilt psychologists performed on data from a series of visual recognition tasks collected in the process of developing a new standard test for expertise in object recognition.

"These results aren't definitive, but they are consistent with the following story," said Gauthier. "Everyone is born with a general ability to recognize objects and the capability to get really good at it. Nearly everyone becomes expert at recognizing faces, because of their importance for social interactions. Most people also develop expertise for recognizing other types of objects due to their jobs, hobbies or interests. Our culture influences which categories we become interested in, which explains the differences between men and women."

The results were published online on Aug. 3 in the Vision Research journal in an article titled, "The Vanderbilt Expertise Test Reveals Domain-General and Domain-Specific Sex Effects in Object Recognition."

"Our motivation was to assess the role that expertise plays in object recognition with a new test that includes many different categories, so we weren't looking for this result," said Professor of Psychology Isabel Gauthier. She directs the lab where post-doctoral fellow Rankin McGugin conducted the study.

"This isn't the first time that sex differences have been found in perceptual tasks. For example, previous studies have shown that men have an advantage in mental rotation tasks. In fact, a recent study looking only at car recognition found that men were better than women but attributed this to the male advantage in mental rotation. Our finding that women are better than men at recognizing objects in other categories suggests that this explanation is incorrect."

Discovery of the sex effect in object recognition also casts doubt on several studies that claim an individual's ability to recognize faces is largely independent of his or her ability to recognize objects.

"Face recognition abilities are exciting to study because they have been found to have a clear genetic basis," said Gauthier, "and many studies conclude that abilities in face recognition are not predicted by abilities in object recognition. But this is usually based on comparing faces to only one object category for men and women."

It took the multi-category analysis to reveal that face recognition abilities are correlated to the ability to recognize different object categories for men and women. For example, men who are better at recognizing vehicles also tend to be better at recognizing faces, while women who are better at recognizing living things tend to be better at recognizing faces.

The researchers modeled their new test after the well-established Cambridge Face Memory Task, which effectively measures a person's ability to recognize faces. After familiarizing themselves with a number of images, participants are shown three images at a time -- one from the study group and two that they haven't seen before -- and then are asked to pick out the image that they had studied.

While one goal of the new study was to compare object and face recognition skills, another goal was to develop a better way to measure who has exceptional skills in one domain: how to find the experts in the recognition of cars or birds or even mushrooms. To do this, the Vanderbilt researchers reasoned that performance on any category of interest needed to be compared to performance on many other categories, to ensure that the self-proclaimed bird expert is not only better with birds than most people, but also better with birds than with most other categories. So they designed the new test with eight categories of visually similar objects: leaves, owls, butterflies, wading birds, mushrooms, cars, planes and motorcycles.

To evaluate the new test, they administered it to 227 subjects -- 75 male and 82 female -- with a mean age of 23. When the results of the entire group were analyzed, the researchers found that increasing the number of categories revealed a large sex difference: Women proved significantly better at recognizing living things while men were better at recognizing vehicles. In addition, the researchers administered a face recognition test to about half of the participants, which allowed them to determine the correlation between vehicle recognition and face recognition in men and the correlation between recognition of living things and faces in women.

Vanderbilt post-doctoral fellow Jennifer Richler as well as Grit Herzmann, a post-doctoral fellow at the University of Colorado, Boulder and Research Assistant Magen Speegle also contributed to the study.

The research was supported by the National Eye Institute grants EYO13441-06A2 and P30-EY008126 and by the National Science Foundation's Temporal Dynamics of Learning Center grant SBE-0542013.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Vanderbilt University.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Rankin W. McGugin, Jennifer J. Richler, Grit Herzmann, Magen Speegle, Isabel Gauthier. The Vanderbilt Expertise Test reveals domain-general and domain-specific sex effects in object recognition. Vision Research, 2012; 69: 10 DOI: 10.1016/j.visres.2012.07.014

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

18 Sep, 2012


-
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/GiRG07ulFyE/120917132022.htm
--
Manage subscription | Powered by rssforward.com
11.04 | 0 komentar | Read More

Cause of chemotherapy resistance in melanoma found

ScienceDaily (Sep. 17, 2012) — Researchers with UC Irvine's Chao Family Comprehensive Cancer Center have identified a major reason why melanoma is largely resistant to chemotherapy.

UCI dermatologist Dr. Anand Ganesan and colleagues found a genetic pathway in melanoma cells that inhibits the cellular mechanism for detecting DNA damage wrought by chemotherapy, thereby building up tolerance to cancer-killing drugs.

Targeting this pathway, comprising the genes RhoJ and Pak1, heralds a new approach to treating the deadly skin cancer, which claims nearly 10,000 U.S. lives each year. Study results appear online in Cancer Research, a journal of the American Association for Cancer Research.

"If we can find a way to turn off the pathway responsible for this resistance, melanoma tumors would suddenly become sensitive to therapies we've been using for the last 20 years," said Ganesan, assistant professor of dermatology and biological chemistry at UCI.

In pursuit of a cause for the chemo tolerance, he and his colleagues performed a genome-wide scan for genes controlling drug resistance in melanoma cells. Their search identified RhoJ, a gene normally involved in blood vessel growth. They saw that in response to drug-induced DNA damage in a melanoma cell, RhoJ activated another gene, Pak1, which initiated a molecular cascade suppressing the cell's ability to sense this damage -- and blocking the apoptosis process.

"Normally, such drug-induced DNA damage would result in cell death," Ganesan said. "But this blunting of DNA damage response allows melanoma cells to mutate and proliferate. Being capable of rapid adaptation and change is a hallmark feature of this challenging form of cancer and makes it very difficult to treat."

On the heels of this discovery, he and colleagues have begun exploring methods to inhibit the genes responsible for this DNA damage tolerance. What they come up with could one day supplement chemotherapy treatments for melanoma, Ganesan added.

Hsiang Ho, Jayavani Aruri, Rubina Kapadia and Hootan Mehr of UCI and Michael A. White of the University of Texas Southwestern Medical Center at Dallas participated in the study, which received support from the National Institutes of Health, the University of California Cancer Research Coordinating Committee, the American Cancer Society, Outrun the Sun Inc. and the Robert A. Welch Foundation.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by University of California - Irvine.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. H. Ho, J. Aruri, R. Kapadia, H. Mehr, M. A. White, A. K. Ganesan. RhoJ and Pak Kinases Regulate Melanoma Chemoresistance by Suppressing Pathways that Sense DNA Damage. Cancer Research, 2012; DOI: 10.1158/0008-5472.CAN-12-0775

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

18 Sep, 2012


-
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/TdqfxrpfVKY/120917132351.htm
--
Manage subscription | Powered by rssforward.com
11.04 | 0 komentar | Read More

First 3-D model of a protein critical to embryo development

ScienceDaily (Sep. 14, 2012) — The first detailed and complete picture of a protein complex that is tied to human birth defects as well as the progression of many forms of cancer has been obtained by an international team of researchers led by scientists with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab). Knowing the architecture of this protein, PRC2, for Polycomb Repressive Complex 2, should be a boon to its future use in the development of new and improved therapeutic drugs.

"We present a complete molecular organization of human PRC2 that offers an invaluable structural context for understanding all of the previous biochemical and functional data that has been collected on this complex," says Berkeley Lab biophysicist Eva Nogales, an electron microscopy expert who led this research. "Our model should also be an invaluable tool for the design of new experiments aimed at asking detailed questions about the mechanisms that enable PRC2 to function and how those mechanisms might be exploited."

Nogales, who holds joint appointments with Berkeley Lab, the University of California (UC) at Berkeley, and the Howard Hughes Medical Institute (HHMI), is one of two corresponding authors of a paper describing this research in the journal eLife. The paper is titled "Molecular Architecture of Human Polycomb Repressive Complex 2." The other corresponding author is Claudio Ciferri, previously a postdoctoral fellow in the Nogales Lab, now with Novartis Vaccines and Diagnostic. Additional authors are Gabriel Lander, Alessio Maiolica, Franz Herzog and Ruedi Aebersold.

The link between PRC2 and embryonic development is well-established not just for humans but across the board for eukaryotic organisms. For example, studies with mice have shown that the deletion of any of PRC2's components results either in the death of an embryo or severe defects during the critical stages of early development. It is also well-established that PRC2 helps control the differentiation (specialization) of embryonic stem cells by acting to silence certain genetic messages with the nucleus of a cell.

"PRC2 controls stem cell differentiation by regulating the expression of specific genes through the binding and methylation of histones, the proteins in chromatin that help bundle DNA into nucleosomes," Nogales explains. "This is why PRC2 has been one of the top targets in drug development efforts by pharmaceutical companies."

Despite the numerous biochemical and molecular studies that have been done on PRC2, little has been known about the protein's overall architecture and the manner in which its different components interact to coordinate histone-binding and methylation. Nogales, Ciferri and their colleagues have closed this knowledge gap with their model, which they painstakingly constructed from data gathered via multiple sources including three-dimensional electron microscopy, mass spectrometry, protein biochemistry, crystal structure docking, and chemical cross-linking.

The 3D model they constructed features a structural reconstruction at 21 Angstroms and shows PRC2 with all its subunits and functional domains forming a complex with the protein called "AEBP2," which serves as a stabilizing co-factor for PRC2. The PRC2-AEBP2 complex was shown to consist of four large lobes interconnected by two narrow arms. Clearly identified within this structure are regions where PRC2 and AEBP2 interact.

"This is a robust model that shows the overall architecture and domain organization of the PRC2-AEBP2 complex with unprecedented detail," says Nogales. "From this model we can see how AEBP2 helps stabilize PRC2 and also how it plays a major role in coordinating the activity of different PRC2 subunits. Our model also provides us with a framework for understanding how various elements of the PRC2 complex involved in regulated histone modification can act either independently or synergistically in response to different chromatin environments."

Not only does this new model put previous biochemical data on PRC2 in perspective, it also points the way to new testable hypotheses on how PRC2 interacts with chromatin that should inspire future research of PRC2 function and regulation. For example, from this model, Nogales, Ciferri and their co-authors have localized the molecular structures of individual domains involved in histone binding and methylation. The data suggests a mechanism as to how PRC2 might work in the chromatin environment.

"PRC2 is recruited at specific sites along the DNA that need to be silenced, aided by regulators such as AEBP2," Nogales says. "Our domain localizations provide important information on how PRC2 can bind nucleosomes during the gene-silencing process. Such information can be used to guide specific deletion or cross-linking mutants for future drug design efforts."

This research was supported by the National Institute of General Medical Sciences, the Howard Hughes Medical Institute and by funding from the European Union Seventh Framework Program PROSPECTS.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by DOE/Lawrence Berkeley National Laboratory.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

18 Sep, 2012


-
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/sToqiWk2dUk/120917124224.htm
--
Manage subscription | Powered by rssforward.com
11.04 | 0 komentar | Read More
techieblogger.com Techie Blogger Techie Blogger